drugset / Trial / NCT06427291
Clinical Study of T3011 Intravesical Instillation for Treatment of NMIBC Patients
NaSingle-groupOpen-labelTreatment
Summary
This is a prospective, open-label, single-arm investigator-initiated clinical study. It is used to evaluate the safety and efficacy of T3011 intravesical instillation in patients with BCG-failure high-risk non-muscle invasive bladder cancer (NMIBC)
Timeline
- Start
- 2023-09-21
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | T3011 | Other / unclassified | 5e+07 unknown | Other |
| Subject | T3011 | Other / unclassified | 5e+08 unknown | Other |
| Subject | T3011 | Other / unclassified | 2e+09 unknown | Other |